Emerging strategies for EphA2 receptor targeting for cancer therapeutics

M Tandon, SV Vemula, SK Mittal - Expert opinion on therapeutic …, 2011 - Taylor & Francis
Importance of the field: High mortality rates with cancers warrant further development of
earlier diagnostics and better treatment strategies. Membrane-bound erythropoietin …

Signaling inputs to invadopodia and podosomes

D Hoshino, KM Branch, AM Weaver - Journal of cell science, 2013 - journals.biologists.com
Remodeling of extracellular matrix (ECM) is a fundamental cell property that allows cells to
alter their microenvironment and move through tissues. Invadopodia and podosomes are …

PTEN and Other PtdIns(3,4,5)P3 Lipid Phosphatases in Breast Cancer

MP Csolle, LM Ooms, A Papa, CA Mitchell - International Journal of …, 2020 - mdpi.com
The phosphoinositide 3-kinase (PI3K)/AKT signalling pathway is hyperactivated in~ 70% of
breast cancers. Class I PI3K generates PtdIns (3, 4, 5) P3 at the plasma membrane in …

SHIP1 inhibition increases immunoregulatory capacity and triggers apoptosis of hematopoietic cancer cells

R Brooks, GM Fuhler, S Iyer, MJ Smith… - The Journal of …, 2010 - journals.aai.org
Genetic studies revealed that SHIP1 limits blood cell production and immune regulatory cell
numbers in vivo. We postulated that molecular targeting of SHIP1 might enhance blood cell …

Therapeutic potential of SH2 domain-containing inositol-5′-phosphatase 1 (SHIP1) and SHIP2 inhibition in cancer

GM Fuhler, R Brooks, B Toms, S Iyer, EA Gengo… - Molecular …, 2012 - Springer
Many tumors present with increased activation of the phosphatidylinositol 3-kinase (PI3K)-
PtdIns (3, 4, 5) P 3-protein kinase B (PKB/Akt) signaling pathway. It has long been thought …

PLEK2 mediates metastasis and vascular invasion via the ubiquitin‐dependent degradation of SHIP2 in non‐small cell lung cancer

DM Wu, SH Deng, J Zhou, R Han, T Liu… - … journal of cancer, 2020 - Wiley Online Library
Metastasis is the leading cause of death for non‐small cell lung cancer (NSCLC) patients.
However, how lung cancer cells invade blood vessels during metastasis remains unclear …

Targeting SHIP1 and SHIP2 in Cancer

C Pedicone, ST Meyer, JD Chisholm, WG Kerr - Cancers, 2021 - mdpi.com
Simple Summary Phosphoinositol signaling pathways and their dysregulation have been
shown to have a fundamental role in health and disease, respectively. The SH2-containing …

Inositol polyphosphate phosphatases in human disease

S Hakim, MC Bertucci, SE Conduit, DL Vuong… - Phosphoinositides and …, 2012 - Springer
Phosphoinositide signalling molecules interact with a plethora of effector proteins to regulate
cell proliferation and survival, vesicular trafficking, metabolism, actin dynamics and many …

Network analysis of the focal adhesion to invadopodia transition identifies a PI3K-PKCα invasive signaling axis

D Hoshino, J Jourquin, SW Emmons, T Miller… - Science …, 2012 - science.org
In cancer, deregulated signaling can produce an invasive cellular phenotype. We modeled
the invasive transition as a theoretical switch between two cytoskeletal structures: focal …

The emerging roles of OSBP-related proteins in cancer: Impacts through phosphoinositide metabolism and protein–protein interactions

VM Olkkonen - Biochemical pharmacology, 2022 - Elsevier
Oxysterol-binding protein-related proteins (ORPs) form a large family of intracellular lipid
binding/transfer proteins. A number of ORPs are implicated in inter-organelle lipid transfer …